We describe a versatile high-performance liquid-chromatographic method for determining homocysteine and other plasma suithydryls.Using three different procedures for preparation of plasma, we determined total, free (non-protein-bound), and reduced forms of homocysteine, cysteine, glutathione, cysteinylglycine, and y-glutamylcysteine in human plasma. Sample preparation involves disulfide reduction with dithiothreitol and protein precipitation with sulfosalicylic acid. The assay utilizes isocratic reversed-phase ion-pair liquid chromatography at pH 2.4, postcolumn derivatization with 4,4'-dithiodipyridine, and colorimetric detection at 324 nm. The intraassay precision (CV) of the method for total homocysteine is 1.5%; the interassay precisionover 2.5 months is 2.5%. The detection limit for homocysteine is <50 nmol/L plasma.
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IndexingTerms
Greatly increased plasma concentrations of homocysteine are found in patients with inborn errors of metabolism that block either the homocysteine catabolism or the folate and vitamin B12-dependent homocysteine remethylation (1). These patients develop precocious arteriosclerosis and early, life-threatening thromboembolism. Homocysteine in high concentration is generally considered to be atherogenic and thrombogenic. In the last decade, >20 case-control studies have consistently shown that plasma homocysteine concentration is very frequently increased in patients with vascular disease (2). Therefore, even mild hyperhomocysteinemia is considered to be a risk factor for vascular disease (2). This and the fact that plasma homocysteine concentration is a sensitive marker for functional vitamin B12 or folate Departments of' Clinical Chemistry and3 Neurology, Universit7 Hospital, S-221 85 Lund, Sweden.
Author for correspondence.
Received November 17, 1992; accepted February 24, 1993.
deficiency (3) (4) (5) have led to an increasing interest in measuring homocysteine in various biological fluids and tissues.
In freshly prepared plasma or serum, almost all homocysteine is in the disulfide form-either bound to protein (70-80%) or to low-molecular-mass sulfhydryls, mainly cysteine (20-30%)-and only traces are found in free sulfhydryl form (6, 7) . Because the term homocysteine is often used in contexts that include several of these homocysteinyl derivatives (2), we use the terms total, free, and reduced to classify these derivatives in plasma. Total 
Materials and Methods

Materials
L-Homocystine, DL-homocysteine, and L-glutathione (oxidized and reduced form) were purchased from Fluka Chemie AG (Buchs, Switzerland). The outlet from the mobile-phase pump was con- To prepare protein-free plasma, we mixed 1.2 mL of plasma (within 30 a after the centrifugation) with 0.3 mL of 150 g/L sulfosalicylic acid, kept this at 4#{176}C for 30 miii, and centrifuged (4000 x g, 4#{176}C, 5 mm). The supernate was stored in sealed ciyotubes at -70 #{176}C until analyzed for free (non-protein-bound) sulihydryls or reduced sullhydryls in plasma. acid and thereafter proceeded as in the procedure just described for plasma. Thus the reaction rates for homocysteine, cysteine, glutathione, and cysteinyiglycmne were similar, but y-glutamylcysteine exhibited a slower reaction rate. The peak areas for homocysteine in relation to coil volume are shown in Figure 2 . We also found that a 
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Conditions for Reduction of Plasma Disulfides
The efficiency of the disulfide reduction was elucidated by varying the time for reduction with a constant amount of DTT (100 pL of 0.1 mol/L DTT per 400 L of plasma) at 37#{176}C. The amount of DTT is about twice the total amount of disulfide bonds in plasma, which mainly consist of the 17 (35) intramolecular disulfide bonds in albumin.
The time was varied from 15s to 15 min. The shortest reduction time (15 s) released about 80% of the plasma hornocysteine released during the most efficient period (15 miii). The liberated homocysteine increased slightly over time between 1 and 15 mm. At 15 mm, the plasma became a gel because of reduction of the intramolecular disulfide bonds. With reduction times >15 mm, the variance in liberated homocysteine increased because the gel was incompletely mixed with sulfosalicylic acid. Increasing the pH of the plasma or using a greater concentration of DTT caused the mixture to become a gel sooner but did not influence the amount of homocysteine liberated. Because the sensitivity is not a problem in the measurement of total homocysteine, the gel formation could be avoided by using a higher sample dilution during the reduction. When the reduction was performed after the protein precipitation, as when assaying free (non-protein-bound) homocysteine, the amount of DTT used was reduced fivefold because of the low amount of disulfide bonds present in the protein-free supernate.
Sensitivity, Accuracy, Linearity, and Precision
The detection limit for homocysteine in plasma, defined as a signal-to-noise ratio >5, is about 50 nmol/L plasma (equal to 3 pmol assayed). The detection limit is the same for the other suiThydryls in plasma.
To obtain this sensitivity, it is necessary to keep to a minimum the absorbance difference between the mobile phase and the reagent as well as the pressure pulsation in the reagent and mobile phase. This is achieved by using the pulse dampers and keeping the regent reservoir at -0 #{176}C. However, because of the relatively high concentrations of total and free homocysteine in plasma, the reagent bottle did not require cooling for analyzing these fractions if the pressure pulsation was kept low.
To test the accuracy of the method for total homocysteine, 75 samples previously analyzed with an amino acid analyzer (with nmnhydrin) Not until 192 h (8 days) at 22#{176}C did we note a substantial decrease in total homocysteine (Figure 3) . Cysteine, glutathione, and cysteinyiglycine showed a similar response pattern. No conclusion could be made for 'y-glutamylcysteine, because its concentration in the plasma sample investigated was too low. 
Effect of Changes in the Mobile Phase
The different peaks in the plasma sample chromatogram were identified by comparing the retention times with those of reference substances.
Use of the mobile phase described Figure 4 shows the chromatograms from a plasma sample analyzed by the methods for total, free (non-proteinbound), and reduced sulihydryls.
The unknown peak at 12.0 mm ( Figure 4A ) was less sensitive to changes in pH and octyl sulfate but was sensitive to changes in phosphate concentrations.
Normal Plasma Concentrationsof the Sulfhydryls
The plasma concentrations of the different fractions of homocysteine, cysteine, glutathione, y-glutamylcysteine, and cysteinyiglycine and their ratios in 10 apparently healthy men are shown in Table 1 . 
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Cys-Gly, cysteinyiglyclne.
The investigated sulihydryl (II) reacts with 4,4'-dithiodipyridine (I) to form a mixed disullide (III) and 4-thiopyridone (IV). The equilibrium of reaction A favors the formation of 4-thiopyridone (IV) because of the stabilizing effect exerted by the thione (IV) form. With nonprotein thiols, reaction B may also occur, even in an excess of reagent, because unmixed disulfides (V) predominate in reactions between nonprotein thiols and aromatic disulfides (35). 4-Thiopyridone (IV) has maximal absorbance at a longer wavelength (324 nm) than the aromatic symmetrical disulfide (I) and the aromatic moieties of the mixed disulfide (III).
Precolumn derivatization techniques rely on detection of the aromatic moieties of the mixed disulfide, whereas in postcoluxnn techniques the thione anion is detected. At least a part of the investigated sulfhydryl will form unmixed disulfides (V) that escape detection when precolumn derivatization is used. This is in contrast with the postcolumn application, where the stoichiometrically formed thione anion is detected. In fact, when we measured homocysteine and cysteine, using precolumn derivatization according to Komuro et al. (29) but replacing DTNB with 4,4'-dithiodipyridine, the chromatogram showed smaller peaks than expected for the mixed disulfides (247 nm), whereas the peaks for the thione anion (324 nm) were larger than expected. This was not the case when we used DTNB according to the procedure described by Komuro et al. (29). We therefore conclude that DTNB may be preferable to dithiodipyridine for precolumn derivatization. However, we prefer postcolumn derivatization with dithiodipyridine, which gives better sensitivity owing to the higher absorbance coefficient and its independence of the equilibrium in reaction B.
Optimal Conditions for Chromatography
To avoid losing sensitivity, one must maintain only a small absorbance difference between reagent and mobile phase. The tendency to pulsation by reciprocating pumps will cause a change in the local reagent concentration. 
Concentrationsof Sulfhydrylsin Plasma
The described method showed good correlation for total homocysteine determined with our earlier described method with a conventional amino acid analyzer (11) and the monobromobimane method described by Refsum et al. (15) . The mean concentration of homocysteine in the samples assayed by the three methods also showed a good agreement.
The dominating total plasma sulfliydryl in the small group of 10 men investigated was cysteine (268 prnol/L) followed by cysteinyiglycine is almost 8%, which is higher than that found for homocysteine, cysteine, and y-glutamylcysteine (Table 1) . Cysteinyiglycine is formed from glutathione, and thus plasma is continuously supplied with reduced cysteinyiglycine, which may account for the relatively high fraction of the reduced form. Homocysteine, cysteine, and y-glutamylcysteine show only a low fraction of the reduced form (about 2-3% of total). This might indicate that these sulfhydryls have a slower turnover rate in plasma than glutathione and cysteinylglycine and therefore become more oxidized.
The described method for total homocysteine has been used in research projects and in routine diagnosis for >1.5 years and has proven to be reliable. Total plasma homocysteine is suggested to be an indicator of intracellular homocysteine metabolism (2). It is not affected by disulfide redistribution after the blood collection, and plasma can be stored for years before analysis. Therefore, it is preferable to analyze total homocysteine for diagnosis of hyperhomocysteinemia.
On the other hand, because the mechanism through which homocysteine exerts its atherogenic effect is unclear, research calls for methods that measure different forms of homocysteine and other plasma thiol compounds.
Furthermore, the measurement of free and reduced homocysteine is an indicator of the thiol redox status in plasma, which might be disturbed and related to the atherogenic process in hyperhomocysteinemia of different origins.
